Serial Number | 79404481 |
Word Mark | LUMIT |
Filing Date | Friday, October 27, 2023 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Friday, September 27, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical agents affecting peripheral nervous system; dietary fiber; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; eye drops; allergy medications; dietetic substances adapted for medical use; bath preparations for medical purposes; diagnostic agents for medical use; slimming tea for medical purposes; pharmaceutical compositions; pharmaceuticals; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis; analgesic balm; nutraceuticals for therapeutic purposes; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations for the treatment of parkinson's disease; antimicrobials for dermatologic use; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparation for skin care; pharmaceutical preparations for skin care; antihypertensives; anti-diabetic pharmaceuticals; anti-cancer preparations; anti-sarcoma preparations; anticoagulants; antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; pharmaceutical preparations for the prevention of disorders of the respiratory system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for respiratory organs; compounds for treating respiratory diseases; pharmaceutical products for treating respiratory diseases; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for treating respiratory diseases. |
Goods and Services | Drug development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; medicine research. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, September 12, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, September 12, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | LuMit Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Event Date | Event Description |
Thursday, September 12, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, September 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 17, 2024 | APPLICATION FILING RECEIPT MAILED |
Wednesday, September 18, 2024 | ASSIGNED TO EXAMINER |
Monday, September 23, 2024 | NON-FINAL ACTION WRITTEN |
Friday, September 27, 2024 | REFUSAL PROCESSED BY MPU |
Saturday, October 19, 2024 | REFUSAL PROCESSED BY IB |
Friday, September 27, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, September 24, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |